A carregar...
Ophthalmic results in patients with macroprolactinomas treated with a new prolactin inhibitor CV 205-502.
Macroprolactinomas are pituitary tumours which have been effectively treated medically since the introduction of bromocriptine. The visual function of 13 patients treated with a new prolactin (PRL) inhibitor CV 205-502 (Sandoz Basle), a potent and selective dopamine D2 receptor agonist, was evaluate...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
1993
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC504657/ https://ncbi.nlm.nih.gov/pubmed/7906538 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|